
Adaptive Biotechnologies Corporation
Free shipping on orders over $99 · 30-day returns
Adaptive Biotechnologies clonoSEQ Assay is an FDA 510(k)-cleared medical device (DEN170080) manufactured by Adaptive Biotechnologies Corporation. This device is classified under the Pathology specialty. FDA Device Class II (Special Controls) — moderate risk, requires 510(k) clearance. FDA clearance granted on September 27, 2018. Regulation: 8.